-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

508. Bone Marrow Failure: Acquired: Poster II

Symposia: Bone Marrow Failure: Acquired Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Bhavisha A. Patel, MD1, Emma M. Groarke, MD2, Ruba Shahloub3*, Jennifer Lotter4*, Jeanine Superata5*, Joelle Khoriaty6*, Kimberly McKernan6*, Uzoamaka Okeke6*, Olga Rios1*, Colin O. Wu, PhD7* and Neal S. Young, MD1

1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
2Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD
3Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda
4Hematology Branch, NHLBI, National Institutes of Health, Bethesda, MD
5Office of the Clinical Director, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
6Office of Clinical Research Support Services, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda
7Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Alexandra Pike, MBBS, FRCPath, MRCP1,2*, Natalie Fox, MSc3*, Claire E McKinley, BSc3*, Louise M Arnold, BSc (hons)2*, Mark Harland, PhD3*, Deborah Clarke, MSc3*, Briony Forrest, BSc2*, Nicola Houghton, BSc2*, Nora Youngs, BSc2*, Emily Charlton, BSc2*, Tapiwa Zhakata, BSc2*, Catherine Barnfield, BSc2*, Ruth Harvey4*, Mary Wu4*, Caitlin Kavanagh4*, Stephen John Richards, PhD, FRCPath3*, Daniel Payne, MSc2*, Abraham Mullasseril Varghese, MBBS, MRCP5*, Sateesh Nagumantry, MBBS6*, Talha Munir, MBBS, MRCP, FRCPath, PhD2*, Petra Muus, MD2, Morag Griffin, FRCPath, MRCP2*, Darren Newton, PhD7*, Peter Hillmen3 and Richard J Kelly, PhD2,3*

1Leeds Institute of Medical Research, University of Leeds, Wakefield, ENG, United Kingdom
2Department of Haematology, St James's University Hospital, Leeds, United Kingdom
3Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom
4The Francis Crick Institute, London, United Kingdom
5Department of Haematology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
6Peterborough City Hospital, Peterborough, United Kingdom
7Leeds Institute of Medical Research, University of Leeds, Leeds, ENG, United Kingdom

Caroline I Piatek, MD1, Flore Sicre De Fontbrune2*, Fahri Sahin3*, Wolfgang Füreder4*, Sandra Fatima Gualandro, MD, PhD5*, Wilma Barcellini, MD6*, Masayo Ogawa, MD7*, Stephan Ortiz, RPh, PhD7*, Ayca Ozol-Godfrey7*, Jeff Szer, MBBS, FRACP8 and Mustafa Yenerel9*

1Jane Anne Nohl Divison of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA
2Hematology and Transplant Unit, Saint Louis Hospital, APHP, Paris, France
3Division of Hematology, Department of Internal Medicine,, Ege University, Izmir, Turkey
4Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
5Division of Haematology, University of São Paulo Medical School, Sao Paulo, Brazil
6Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
7Alexion, AstraZeneca Rare Disease, Boston, MA
8Department of Clinical Haematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, VIC, Australia, Melbourne, VIC, Australia
9Division of Hematology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey, Istanbul, TUR

Austin Kulasekararaj, MD, MBBS, FRCPath, MRCP1, Hubert Schrezenmeier, MD2,3, Kensuke Usuki, MD, PhD4, Aleksander Kulagin5*, Sandra Fatima Gualandro, MD, PhD6*, Rosario Notaro7,8*, Masayo Ogawa, MD9*, Ji Yu10*, Ami Patel, PhD9*, Yogesh Patel9*, Wolfgang Füreder11*, Regis Peffault De Latour12* and Jong-Wook Lee, MD13

1Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, ENG, United Kingdom
2German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm, Germany
3University of Ulm, Ulm, Germany
4NTT Medical Center Tokyo, Tokyo, Japan
55RM Gorbacheva Research Institute, Pavlov University, St Petersburg, RUS
6Division of Haematology, University of São Paulo Medical School, Sao Paulo, Brazil
7Istituto Per Studio, La Prevenzione E La Rete Oncologica (ISPRO), Florence, ITA
8Haematology, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
9Alexion, AstraZeneca Rare Disease, Boston, MA
10Alexion, AstraZeneca Rare Disease, Boston
11Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
12Hôpital Saint-Louis,, Paris, France
13Department of Hematology, Seoul St. Mary's Hospital Catholic University of Korea, Seoul, South Korea

Gi June Min1, Sung-Soo Park2*, Silvia Park1*, Jae-Ho Yoon, MD2, Seung-Hwan Shin3*, Sung-Eun Lee, MD4*, Byoung Sik Cho1*, Ki-Seong Eom2*, Yoo-Jin Kim2, Seok Lee2, Hee-Je Kim5*, Chang-Ki Min2*, Seok-Goo Cho1* and Jong-Wook Lee, MD2

1Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
2Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Department of Hematology, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
4Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
5Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Seoul, Korea, Republic of (South)

Richard J. Kelly, BSc, MD1*, Nicola Houghton, BSc2*, Talha Munir, MBBS, MRCP, FRCPath, PhD3*, Petra Muus, MD2, Nora Youngs, BSc2*, Lisa Aurand, MD4, Kosalai Mohan4*, Brian Senk4*, Rodrigo Pavani4*, Lorah Perlee, PhD4*, Amal Souttou4* and Morag Griffin, FRCPath, MRCP2*

1Department of Haematology, St. James’s University Hospital, Leeds, United Kingdom
2Department of Haematology, St James's University Hospital, Leeds, United Kingdom
3Department of Haematology, St. James's University Hospital, Leeds, United Kingdom
4Regeneron Pharmaceuticals, Inc., Tarrytown, NY

Shichong Wang, MD1*, Jiali Huo2*, Yilin Liu2*, Lingyun Chen2*, Xiang Ren2*, Xingxin Li2*, Min Wang2*, Peng Jin2*, Jinbo Huang2*, Neng Nie2*, Jing Zhang2*, Yingqi Shao2*, Meili Ge2*, Yingchang Mi, MD2 and Yizhou Zheng2*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tian Jin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China

Zexing Sun1,2*, Yilei Hong1,2*, Wanzhi Jiang1,2*, Yingying Shen1*, Huijin Hu1*, Tonglin Hu1*, Qi Liu1,2*, Zhenchao Zhuang3*, Yuhong Zhou1*, Baodong Ye, MD4* and Dijiong Wu, MD, PhD1

1Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China
2The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China
3Department of Clinical Laboratory, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China
4The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China

Sukanya Gogoi, MD1*, Jennifer Vidler, MBBS, MRCP, FRCPath2*, Manujasri Wimalachandra, MD, FRCPath, MBBS, MRCP3*, Wasanthi Wickramasinghe, MBBS, MRCP, FRCPath3* and Austin Kulasekararaj, MD, MBBS, FRCPath, MRCP4,5,6

1Department of Haematological Medicine, King's College Hospital , King's College Hospital NHS Foundation Trust, London, ENG, United Kingdom
2Department of Haematological Medicine, King's College Hospital, King's College Hospital NHS Foundation Trust, London, United Kingdom
3Haematology, King's College Hospital, King's College Hospital NHS Foundation Trust, London, United Kingdom
4Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, ENG, United Kingdom
5National Institute for Health Research and Wellcome King's Clinical Research Facility, London, United Kingdom
6Department of Haematological Medicine, King's College Hospital, London, United Kingdom

Matthew P Connor, MD1, Neeharika Prathapa, MBBS1*, Noelle V. Frey, MD, MS1, Saar Gill, MD, PhD1, Elizabeth O Hexner, MD, MSTR1, Ximena Jordan Bruno, MD1, Catherine Lai, MD1, Alison W Loren, MD1, Selina M Luger, MD, FRCPC1, Andrew H Matthews, MD1*, Shannon R McCurdy, MD1, Alexander Perl1, David L. Porter, MD1, Arlene Zeringue2*, Joseph H. Oved, MD3,4, Timothy S Olson, MD, PhD4,5, Keith W Pratz, MD1 and Daria V Babushok, MD, PhD1,4

1Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
2Information Services, University of Pennsylvania, Philadelphia, PA
3Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY
4Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA
5Department of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA

Wenrui Yang1*, Baohang Zhang1*, Xiangrong Hu1*, Li Zhang1*, Liping Jing, MD2*, Xin Zhao, md1 and Fengkui Zhang1*

1Anemia Therapeutic Center, Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, China
2Anemia Therapeutic Center, Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, AL, China

Alexander Röth, MD1, Christopher J. Patriquin2*, Jeff Szer, MBBS, FRACP3, Louis Terriou4*, Ami Patel, PhD5*, Philippe Gustovic, MD, MSc5*, Jun-Ichi Nishimura, MD, PhD6 and Robert A. Brodsky, MD7

1Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
2Division of Medical Oncology & Hematology, University Health Network, Toronto, Canada
3Department of Clinical Haematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, VIC, Australia, Melbourne, VIC, Australia
4Service de Médecine Interne et Immunologie Clinique, CHU Lille, Lille, France
5Alexion, AstraZeneca Rare Disease, Boston, MA
6Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
7Division of Hematology, Johns Hopkins Medicine, Baltimore, MD

Robert Schmouder1*, Noemi Kaetterer2*, Kenneth Kulmatycki3* and Prasanna Kumar Nidamarthy4*

1Novartis Pharmaceuticals Corporation, East Hanover, NJ
2Novartis Pharma AG, Basel, Switzerland
3Novartis Institutes of Biomedical Research, Cambridge, MA
4Novartis Healthcare Pvt. Ltd., Hyderabad, India

Hiroyuki Takamori, MD1*, Yasutaka Ueda2*, Yoshikazu Matsuoka, PhD3*, Tatsuya Fujioka, MD, PhD3*, Hideki Makishima, MD, PhD4, Yoshiko Murakami, MD, PhD5*, Taroh Kinoshita, PhD5, Satoru Miyano, PhD6*, Yuzuru Kanakura, MD, PhD2, Jun-Ichi Nishimura, MD, PhD2, Naoki Hosen, MD, PhD2, Seishi Ogawa7 and Yasuhito Nannya, MD, PhD8

1Division of Hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo, Minato-Ku, Japan
2Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
3Department of iPS Stem Cell Regenerative Medicine, Kansai Medical University, Osaka, JPN
4Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
5Laboratory of Immunoglycobiology, Osaka University Rsrch. Inst. for Microbial Diseases, Osaka, JPN
6M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan
7Department of Pathology and Tumor Biology, Kyoto University Graduate School of Medicine, Sakyoku, KYO, Japan
8Division of Hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Meili Ge*, Jiali Huo*, Xiang Ren*, Jinbo Huang*, Min Wang*, Neng Nie*, Jing Zhang*, Peng Jin*, Yingchang Mi, MD, Yingqi Shao* and Yizhou Zheng*

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China

Josaura Fernandez Sanchez, MD1,2, Arushana Maknojia3*, Enrico Moiso, PhD4*, Nusrat Shaikh5*, Hope Hendricks, MD6*, Hannah Yan, BA, PhD7*, Ritu Banerjee, MD, PhD8*, Jeremy Schraw, PhD2,9*, Megan Baldridge, MD, PhD10* and Katherine Y. King, MD, PhD11

1Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX
2Texas Children’s Cancer and Hematology Centers, Houston, TX
3Immunology and Microbiology Program, Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX
4Koch Institute for Integrative Cancer research at MIT, Cambridge, MA
5Pediatrics Research Resources Office, Baylor College of Medicine, Houston, TX
6Vanderbilt University Medical Center, Vanderbilt University, Nashville, TN
7Immunology Program, Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX
8Vanderbilt University Medical Center, Nashville, TN
9Center for Epidemiology and Population Health, Department of Pediatrics, Baylor College of Medicine, Houston, TX
10Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO
11Pediatric Infectious Diseases, Baylor College of Medicine, Houston, TX

Jun Ho Jang, MD, PhD1, Soo Min Lim2*, Ciprian Tomuleasa3,4,5*, Hanna Oliynyk6*, Theerin Lanamtieng7*, Jihye Park, DVM, BS8*, Younsoo Kim8*, Jinah Jung, MD, PhD8* and Paola Russo, MD, PhD8*

1Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
2Sultanah Aminah Hospital, Johor, Malaysia
3Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
4Department of Hematology, Ion Chiricuta Clinical Cancer Center,, Cluj-Napoca, Romania
5Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
6Department of Hematology, Vinnytsia M I Pyrohov Regional Clinical Hospital, Vinnytsia, Ukraine, Vinnytsia, Ukraine
7Division of Hematology, Department of Internal Medicine, Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand, Khon Kaen, Thailand
8Samsung Bioepis, Incheon, Korea, Republic of (South)

*signifies non-member of ASH